APA

Halpern W. G., Ameri M., Bowman C. J., Elwell M. R., Mirsky M. L., Oliver J., Regan K. S., Remick A. K., Sutherland V. L., Thompson K. E., Tremblay C., Yoshida M. & Tomlinson L. (20171201). Scientific and Regulatory Policy Committee Points to Consider Review: Inclusion of Reproductive and Pathology End Points for Assessment of Reproductive and Developmental Toxicity in Pharmaceutical Drug Development. : Toxicologic pathology.

Chicago

Halpern Wendy G, Ameri Mehrdad, Bowman Christopher J, Elwell Michael R, Mirsky Michael L, Oliver Julian, Regan Karen S, Remick Amera K, Sutherland Vicki L, Thompson Kary E, Tremblay Claudine, Yoshida Midori and Tomlinson Lindsay. 20171201. Scientific and Regulatory Policy Committee Points to Consider Review: Inclusion of Reproductive and Pathology End Points for Assessment of Reproductive and Developmental Toxicity in Pharmaceutical Drug Development. : Toxicologic pathology.

Harvard

Halpern W. G., Ameri M., Bowman C. J., Elwell M. R., Mirsky M. L., Oliver J., Regan K. S., Remick A. K., Sutherland V. L., Thompson K. E., Tremblay C., Yoshida M. and Tomlinson L. (20171201). Scientific and Regulatory Policy Committee Points to Consider Review: Inclusion of Reproductive and Pathology End Points for Assessment of Reproductive and Developmental Toxicity in Pharmaceutical Drug Development. : Toxicologic pathology.

MLA

Halpern Wendy G, Ameri Mehrdad, Bowman Christopher J, Elwell Michael R, Mirsky Michael L, Oliver Julian, Regan Karen S, Remick Amera K, Sutherland Vicki L, Thompson Kary E, Tremblay Claudine, Yoshida Midori and Tomlinson Lindsay. Scientific and Regulatory Policy Committee Points to Consider Review: Inclusion of Reproductive and Pathology End Points for Assessment of Reproductive and Developmental Toxicity in Pharmaceutical Drug Development. : Toxicologic pathology. 20171201.